Abstract
We report herein the synthesis and application of a novel tetradentate ruthenium(II) complex 1 containing a tris(2-pyridylmethyl)amine (tpa) ligand as an inhibitor of β-amyloid fibrillogenesis. [Ru(tpa)(bt)]ClO4 1 (bt =2-acetylbenzo[b]thiophene-3-olate) showed significant inhibition of Aβ(1-40) peptide aggregation in vitro, which was confirmed by a Thioflavin T assay and transmission electron microscopy imaging.
Original language | English |
---|---|
Pages (from-to) | 434-438 |
Number of pages | 5 |
Journal | Current Alzheimer Research |
Volume | 12 |
Issue number | 5 |
DOIs | |
Publication status | Published - 2015 |
Scopus Subject Areas
- Neurology
- Clinical Neurology
User-Defined Keywords
- 2-acetylbenzo[b]thiophen-3-olate
- Alzheimer's disease
- Beta-amyloid
- Ruthenium(II)
- Tris(2-pyridylmethyl)amine